Align Technology/$ALGN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Align Technology
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
Ticker
$ALGN
Sector
Primary listing
Industry
Health Care Equipment and Supplies
Headquarters
Employees
21,200
ISIN
US0162551016
Website
Align Technology Metrics
BasicAdvanced
$14B
34.96
$5.50
1.64
-
Price and volume
Market cap
$14B
Beta
1.64
52-week high
$263.24
52-week low
$141.74
Average daily volume
849K
Financial strength
Current ratio
1.206
Quick ratio
0.972
Long term debt to equity
2.279
Total debt to equity
3.124
Profitability
EBITDA (TTM)
810.151
Gross margin (TTM)
70.02%
Net profit margin (TTM)
10.29%
Operating margin (TTM)
16.55%
Effective tax rate (TTM)
30.70%
Revenue per employee (TTM)
$190,000
Management effectiveness
Return on assets (TTM)
6.72%
Return on equity (TTM)
10.84%
Valuation
Price to earnings (TTM)
34.962
Price to revenue (TTM)
3.597
Price to book
3.73
Price to tangible book (TTM)
4.37
Price to free cash flow (TTM)
22.143
Free cash flow yield (TTM)
4.52%
Free cash flow per share (TTM)
868.31%
Growth
Revenue change (TTM)
1.64%
Earnings per share change (TTM)
-9.32%
3-year revenue growth (CAGR)
-0.42%
10-year revenue growth (CAGR)
17.72%
3-year earnings per share growth (CAGR)
-14.77%
10-year earnings per share growth (CAGR)
11.69%
What the Analysts think about Align Technology
Analyst ratings (Buy, Hold, Sell) for Align Technology stock.
Bulls say / Bears say
Align Technology's recent acquisition of Cubicure GmbH enhances its 3D printing capabilities, potentially leading to more efficient production processes and innovative product offerings. (Align Technology Acquires Cubicure GmbH)
The company's Invisalign system continues to dominate the clear aligner market, with over 14.5 million patients treated worldwide, indicating strong brand recognition and customer trust. (Align Technology Overview)
Align Technology's strategic partnerships and continuous product innovations position it well to capture a growing share of the orthodontic market. (Align Technology Overview)
Align Technology's Q3 2023 revenue of $960.2 million fell short of the consensus estimate of $996.5 million, indicating potential challenges in meeting market expectations. (Why Align Technology Stock Is Crashing Today)
The company reduced its full-year 2023 revenue guidance to a range of $3.83 billion to $3.85 billion from the previous outlook of $3.97 billion to $3.99 billion, reflecting a more challenging macroeconomic environment. (Why Align Technology Stock Is Crashing Today)
Align Technology's stock experienced a significant decline of approximately 24.6% following the announcement of its Q3 2023 results, raising concerns about investor confidence. (Why Align Technology Stock Is Crashing Today)
Data summarised monthly by Lightyear AI. Last updated on 6 Jul 2025.
Align Technology Financial Performance
Revenues and expenses
Align Technology Earnings Performance
Company profitability
Align Technology News
AllArticlesVideos
Align Technology's Invisalign® Brand Brings Teen Confidence and Smiles in First-Time Film Collab With Disney's "Freakier Friday"
Business Wire·2 days ago
Align Technology Announces Invisalign® System With Mandibular Advancement Featuring Occlusal Blocks for Class II Skeletal and Dental Correction
Business Wire·4 days ago
Invisalign® Palatal Expander System by Align Technology Now Available in India for Skeletal and Dental Expansion in Growing Patients
Business Wire·4 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Align Technology stock?
Align Technology (ALGN) has a market cap of $14B as of July 18, 2025.
What is the P/E ratio for Align Technology stock?
The price to earnings (P/E) ratio for Align Technology (ALGN) stock is 34.96 as of July 18, 2025.
Does Align Technology stock pay dividends?
No, Align Technology (ALGN) stock does not pay dividends to its shareholders as of July 18, 2025.
When is the next Align Technology dividend payment date?
Align Technology (ALGN) stock does not pay dividends to its shareholders.
What is the beta indicator for Align Technology?
Align Technology (ALGN) has a beta rating of 1.64. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.